Free Trial

CRA International (CRAI) Competitors

CRA International logo
$201.94 -2.34 (-1.15%)
(As of 02:10 PM ET)

CRAI vs. EXPO, DNB, CBZ, ICFI, VSEC, HURN, FC, ACTG, MG, and OMEX

Should you be buying CRA International stock or one of its competitors? The main competitors of CRA International include Exponent (EXPO), Dun & Bradstreet (DNB), CBIZ (CBZ), ICF International (ICFI), VSE (VSEC), Huron Consulting Group (HURN), Franklin Covey (FC), Acacia Research (ACTG), Mistras Group (MG), and Odyssey Marine Exploration (OMEX). These companies are all part of the "research & consulting services" industry.

CRA International vs.

CRA International (NASDAQ:CRAI) and Exponent (NASDAQ:EXPO) are both business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, community ranking, valuation, profitability, risk, earnings, institutional ownership and media sentiment.

CRA International pays an annual dividend of $1.68 per share and has a dividend yield of 0.8%. Exponent pays an annual dividend of $1.12 per share and has a dividend yield of 1.1%. CRA International pays out 27.2% of its earnings in the form of a dividend. Exponent pays out 54.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Exponent has raised its dividend for 11 consecutive years. Exponent is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Exponent had 2 more articles in the media than CRA International. MarketBeat recorded 12 mentions for Exponent and 10 mentions for CRA International. CRA International's average media sentiment score of 0.84 beat Exponent's score of 0.52 indicating that CRA International is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CRA International
2 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Exponent
5 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

CRA International has a beta of 1.13, suggesting that its share price is 13% more volatile than the S&P 500. Comparatively, Exponent has a beta of 0.69, suggesting that its share price is 31% less volatile than the S&P 500.

Exponent has lower revenue, but higher earnings than CRA International. CRA International is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CRA International$623.98M2.19$38.48M$6.1832.68
Exponent$544.65M9.65$100.34M$2.0750.03

84.1% of CRA International shares are owned by institutional investors. Comparatively, 92.4% of Exponent shares are owned by institutional investors. 5.2% of CRA International shares are owned by company insiders. Comparatively, 2.1% of Exponent shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Exponent has a net margin of 19.52% compared to CRA International's net margin of 6.41%. Exponent's return on equity of 27.73% beat CRA International's return on equity.

Company Net Margins Return on Equity Return on Assets
CRA International6.41% 24.46% 8.98%
Exponent 19.52%27.73%15.59%

CRA International presently has a consensus price target of $212.00, indicating a potential upside of 4.98%. Exponent has a consensus price target of $120.00, indicating a potential upside of 15.86%. Given Exponent's higher possible upside, analysts clearly believe Exponent is more favorable than CRA International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CRA International
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Exponent
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Exponent received 130 more outperform votes than CRA International when rated by MarketBeat users. Likewise, 63.17% of users gave Exponent an outperform vote while only 59.40% of users gave CRA International an outperform vote.

CompanyUnderperformOutperform
CRA InternationalOutperform Votes
177
59.40%
Underperform Votes
121
40.60%
ExponentOutperform Votes
307
63.17%
Underperform Votes
179
36.83%

Summary

Exponent beats CRA International on 13 of the 19 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRAI vs. The Competition

MetricCRA InternationalLegal services IndustryBusiness SectorNASDAQ Exchange
Market Cap$1.37B$1.38B$6.91B$8.89B
Dividend Yield0.82%0.82%2.88%4.02%
P/E Ratio32.6833.0646.0118.06
Price / Sales2.192.20281.8176.05
Price / Cash21.8021.8027.1336.30
Price / Book6.696.724.726.01
Net Income$38.48M$38.48M$120.79M$223.88M
7 Day Performance7.30%7.80%5.49%3.41%
1 Month Performance6.62%7.11%6.13%7.41%
1 Year Performance124.63%125.67%33.30%32.40%

CRA International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CRAI
CRA International
2.6854 of 5 stars
$201.94
-1.1%
$212.00
+5.0%
+127.2%$1.37B$623.98M32.681,004Short Interest ↓
Analyst Revision
EXPO
Exponent
3.8162 of 5 stars
$104.97
+0.7%
N/A+44.0%$5.33B$536.77M50.711,320
DNB
Dun & Bradstreet
2.0425 of 5 stars
$12.33
+0.9%
N/A+34.6%$5.32B$2.31B-154.136,414Short Interest ↑
CBZ
CBIZ
3.7401 of 5 stars
$77.81
+0.5%
N/A+39.2%$3.91B$1.59B32.976,700Short Interest ↑
ICFI
ICF International
3.1691 of 5 stars
$171.64
+1.7%
N/A+27.4%$3.22B$1.96B30.179,000Short Interest ↑
VSEC
VSE
2.7047 of 5 stars
$117.80
+3.0%
N/A+103.4%$2.40B$860.49M36.251,200Earnings Report
Analyst Revision
HURN
Huron Consulting Group
3.9933 of 5 stars
$127.43
-0.2%
N/A+24.2%$2.26B$1.40B27.706,480Short Interest ↑
FC
Franklin Covey
4.5865 of 5 stars
$38.98
+3.8%
N/A+3.5%$510.25M$287.23M22.401,160Earnings Report
Short Interest ↓
Analyst Revision
News Coverage
High Trading Volume
ACTG
Acacia Research
3.1588 of 5 stars
$4.69
+0.2%
N/A+30.3%$473.77M$125.10M7.33290News Coverage
Gap Down
MG
Mistras Group
4.5681 of 5 stars
$9.36
+2.9%
N/A+57.6%$290.25M$705.47M26.744,800
OMEX
Odyssey Marine Exploration
N/A$0.50
-7.5%
N/A-87.5%$10.21M$800,000.000.0010Upcoming Earnings
Short Interest ↓
Positive News

Related Companies and Tools


This page (NASDAQ:CRAI) was last updated on 11/12/2024 by MarketBeat.com Staff
From Our Partners